Stocks › TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA·NYSE·USD
$39.23
+0.69 (+1.79%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TEVAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of TEVA by members of U.S. Congress · 30 on record · 1 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Alan ArmstrongAlan ArmstrongSenate · R · OK TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$1,001 - $15,000
Jul 21, 2026 Mar 30, 2026 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$15,001 - $50,000
Dec 2, 2020 Nov 13, 2020 Filing ↗
Donna ShalalaDonna ShalalaHouse · D · FL TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
May 15, 2020 May 7, 2020 Filing ↗
David E. PriceDavid E. PriceHouse · D · NC TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Jul 11, 2019 Jun 19, 2019 Filing ↗
Patty MurrayPatty MurraySenate · D · WA TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Jun 22, 2017 Jun 15, 2017 Filing ↗
Francis RooneyFrancis RooneyHouse · R · FL TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$1,001 - $15,000
Feb 17, 2017 Feb 7, 2017 Filing ↗
Cheri BustosCheri BustosHouse · D · IL TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Feb 9, 2017 Jan 30, 2017 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$15,001 - $50,000
Jan 5, 2017 Dec 20, 2016 Filing ↗
Angus S. King, Jr.Angus S. King, Jr.Senate · I · ME TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Nov 10, 2016 Oct 19, 2016 Filing ↗
K. Michael ConawayK. Michael ConawayHouse · R · TX TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Oct 12, 2016 Sep 12, 2016 Filing ↗
K. Michael ConawayK. Michael ConawayHouse · R · TX TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Jun 3, 2016 May 11, 2016 Filing ↗
K. Michael ConawayK. Michael ConawayHouse · R · TX TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Jun 3, 2016 May 4, 2016 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$1,001 - $15,000
Feb 25, 2016 Feb 12, 2016 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$15,001 - $50,000
Nov 13, 2015 Oct 22, 2015 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$15,001 - $50,000
Sep 18, 2015 Sep 11, 2015 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$15,001 - $50,000
Aug 5, 2015 Jul 27, 2015 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$15,001 - $50,000
Jul 22, 2015 Jul 13, 2015 Filing ↗
Thomas MacArthurThomas MacArthurHouse · R · NJ TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Mar 5, 2015 Jan 27, 2015 Filing ↗
Thomas MacArthurThomas MacArthurHouse · R · NJ TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$1,001 - $15,000
Mar 5, 2015 Jan 6, 2015 Filing ↗
K. Michael ConawayK. Michael ConawayHouse · R · TX TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Mar 3, 2015 Feb 9, 2015 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$1,001 - $15,000
Feb 12, 2015 Feb 2, 2015 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Sale
$15,001 - $50,000
Feb 12, 2015 — Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$1,001 - $15,000
Feb 10, 2015 Jan 22, 2015 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$1,001 - $15,000
Jan 26, 2015 Jan 8, 2015 Filing ↗
Alan S. LowenthalAlan S. LowenthalHouse · D · CA TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Stock Purchase
$15,001 - $50,000
Jan 14, 2015 Dec 19, 2014 Filing ↗

Whale Activity

Position changes in TEVA reported for 2026-09-30 by 975 institutional filers
Increased: 5New: 310Held: 8Decreased: 9Closed: 372No prior filing: 271
  • Increased5
  • New310
  • Held8
  • Decreased9
  • Closed372
  • No prior filing271

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by TEVA insiders, by quarter · Form 4
-2.0M-1.0M01.0M2.0M2025 Q1: -696.7K2025 Q12025 Q2: -399.9K2025 Q22025 Q3: -57.7K2025 Q32025 Q4: -742.6K2025 Q42026 Q1: -1.7M2026 Q12026 Q2: -539.9K2026 Q22026 Q3: -441.8K2026 Q32026 Q4: -429.3K2026 Q4

Recent Insider Transactions

797 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Sabag MarkSee "Remarks" Sale −44.7K $44.14 $2.0M Nov 12, 2026 Form 4 ↗
Daniell RichardEVP, Europe Commercial Sale −20.0K $42.80 $856K Nov 11, 2026 Form 4 ↗
Francis Richard DPresident and CEO Sale −250.0K $42.24 $10.6M Nov 10, 2026 Form 4 ↗
Daniell RichardEVP, Europe Commercial Sale −25.0K $42.91 $1.1M Nov 9, 2026 Form 4 ↗
Weiss AmirChief Accounting Officer Sale −9,534 $43.03 $410K Nov 9, 2026 Form 4 ↗
Weiss AmirChief Accounting Officer Sale −7,093 $43.03 $305K Nov 9, 2026 Form 4 ↗
Weiss AmirChief Accounting Officer Sale −662 $43.15 $29K Nov 9, 2026 Form 4 ↗
Sabag MarkSee "Remarks" Sale −46.0K $41.93 $1.9M Nov 5, 2026 Form 4 ↗
Bergwerk DovInterim Cheif Legal Officer Sale −8,755 $41.72 $365K Nov 4, 2026 Form 4 ↗
Bergwerk DovInterim Cheif Legal Officer Sale −17.5K $41.72 $730K Nov 4, 2026 Form 4 ↗
Savage BrianInterim Chief Legal Officer Sale −314 $38.70 $12K Sep 18, 2026 Form 4 ↗
Savage BrianInterim Chief Legal Officer Sale −2,525 $39.15 $99K Sep 18, 2026 Form 4 ↗
Savage BrianInterim Chief Legal Officer Sale −4,503 $38.69 $174K Sep 18, 2026 Form 4 ↗
Savage BrianInterim Chief Legal Officer Option exercise +4,503 $34.70 $156K Sep 18, 2026 Form 4 ↗
MIGNONE ROBERTODirector Sale −367.6K $39.06 $14.4M Sep 18, 2026 Form 4 ↗
Weiss AmirChief Accounting Officer Sale −2,500 $37.63 $94K Aug 21, 2026 Form 4 ↗
Weiss AmirChief Accounting Officer Option exercise +2,500 $19.61 $49K Aug 21, 2026 Form 4 ↗
Weiss AmirChief Accounting Officer Sale −6,945 $37.61 $261K Aug 21, 2026 Form 4 ↗
Satchi-Fainaro RonitDirector Sale −415 $37.25 $15K Aug 21, 2026 Form 4 ↗
Lippman EvanEVP, Business Development Sale −18.6K $36.57 $680K Aug 17, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding TEVA · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
VANGUARD STAR FUNDS
17.1M$607.8M0.09%Jul 31, 2026
VANGUARD DEVELOPED MARKETS INDEX FUND
VANGUARD TAX-MANAGED FUNDS
11.3M$382.6M0.12%Jun 30, 2026
VANGUARD FTSE ALL-WORLD EX-US INDEX FUND
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
2.8M$98.4M0.10%Jul 31, 2026
SOUND SHORE FUND
SOUND SHORE FUND, INC.
1.2M$46.5M4.87%Sep 30, 2026
VANGUARD TOTAL WORLD STOCK INDEX FUND
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
984.9K$35.0M0.04%Jul 31, 2026
VANGUARD ESG INTERNATIONAL STOCK ETF
VANGUARD WORLD FUND
237.1K$8.5M0.12%Aug 31, 2026
Empower International Index Fund
EMPOWER FUNDS, INC.
187.2K$7.4M0.21%Sep 30, 2026
Empower International Value Fund
EMPOWER FUNDS, INC.
71.1K$2.8M0.18%Sep 30, 2026
Empower Core Strategies: International Equity Fund
EMPOWER FUNDS, INC.
43.6K$1.7M0.14%Sep 30, 2026
Invesco International Developed Dynamic Multifactor ETF
Invesco Exchange-Traded Self-Indexed Fund Trust
17.6K$632K0.06%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list TEVA's shares (CUSIP M8769Q102), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Phoenix Financial Ltd.SCHEDULE 13G/A · passive (13G) · 56.6M shares4.8%
    Nov 16, 2026 · ↗
  • MENORA MIVTACHIM HOLDINGS LTD.SCHEDULE 13G/A · passive (13G) · 58.2M shares5.0%
    Nov 10, 2026 · ↗
  • Harel Insurance Investments & Financial Services Ltd.SCHEDULE 13G/A · passive (13G) · 70.4M shares6.0%
    Nov 2, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming TEVA PHARMACEUTICAL INDUSTRIES LTD as client

No lobbying filings found naming TEVA PHARMACEUTICAL INDUSTRIES LTD as the client.

Government Contracts

Federal awards to TEVA PHARMACEUTICAL INDUSTRIES LTD · USAspending

No federal contract awards found for TEVA PHARMACEUTICAL INDUSTRIES LTD.

U.S. Patents

Recent USPTO applications naming TEVA PHARMACEUTICAL INDUSTRIES LTD

No USPTO patent applications found for TEVA PHARMACEUTICAL INDUSTRIES LTD.

Annual Financials

From TEVA's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$17.26B$16.54B$15.85B$14.93B$15.88B
Operating income$2.16B-$303.0M$433.0M-$2.20B$1.72B
Net income$1.41B-$1.64B-$559.0M-$2.45B$417.0M
Diluted EPS$1.21-$1.45-$0.50-$2.20$0.38
Operating cash flow$1.65B$1.25B$1.37B$1.59B$798.0M
Cash and equivalents$3.56B$3.30B$3.23B$2.80B$2.17B
Total assets$40.75B$39.33B$43.48B$44.01B$47.67B
Total liabilities$32.83B$33.61B$35.35B$35.41B$36.42B
Shareholders' equity$7.91B$5.37B$7.51B$7.80B$10.28B

As TEVA PHARMACEUTICAL INDUSTRIES LTD tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 3, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitJul 1, 2004
  • 2-for-1Stock splitDec 6, 2002
  • 2-for-1Stock splitFeb 23, 2000
  • 2-for-1Stock splitApr 14, 1993

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureNov 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 3, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeOct 29, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationSep 16, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsSep 14, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsSep 11, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsSep 3, 2026
    EDGAR ↗
  • 8-K · Items 3.03, 9.01Modification of rightsSep 3, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsJul 29, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteMay 28, 2026
    EDGAR ↗

About TEVA PHARMACEUTICAL INDUSTRIES LTD

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersTEL AVIV
IncorporatedL3
Former namesTEVA PHARMACEUTICAL INDUSTRIES LIMITED